Whereas cyp3a4 is predominantly expressed in the liver, cyp3a5 is upregulated in cancer, contributing to drug resistance. Selective inhibitors of cyp3a5 are, therefore, critical to. Topical clobetasol propionate is used to treat nonmelanoma skin cancer, but it may cause cutaneous adverse effects.
The Untold Story: Overtime Megan And The Legal Battles Ahead
The JuicyJoycey Leak: The Aftermath
The Zoe Moore Leak: The Real Victims